Premacular hemorrhage due to isotretinoin use. (June 2013)

• Record Type: Journal Article
• Authors: Onder, Halil Ibrahim; Turan, Hakan; Kilic, Ali Cagri; Kaya, Murat; Tunc, Murat
• Is Part Of: Cutaneous and ocular toxicology. Volume 32:Number 2(2013:Jun.)
• Page Start: 170
• Page End: 172
• Publication Date: 2013-06
• Subjects: Dermatotoxicology -- Periodicals; Ocular toxicology -- Periodicals; Ocular pharmacology -- Periodicals; Dermatopharmacology -- Periodicals; Toxicology -- Periodicals; 615.9
• DOI: 10.3109/15569527.2012.676121
• Languages: English
• ISSNs: 1556-9527

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p>Isotretinoin is a vitamin A derivative used for serious acne that is refractory to other modes of treatment. The most common side effects include dryness of the skin and mucous membranes. Itching as a result of neurological, hematological and ocular side effects has also been reported. Here, we present a 19-year-old female patient who developed premacular hemorrhage and consequent loss of vision in the left eye after oral use of isotretinoin. To the best of our knowledge, this is the first report of the development of premacular hemorrhage as a result of isotretinoin use.</p> </abstract>